Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Medicine, Tuberculosis, Bedaquiline, Internal medicine, Public health, and Pandemic.
Post-TB Lung Disease: Where are we to Respond to This Priority?
Beyond a cure for TB: confronting the hidden burden of post-TB lung disease
Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study
Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects
Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study
The definition of tuberculosis infection based on the spectrum of tuberculosis disease
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
Epidemic and pandemic viral infections: impact on tuberculosis and the lung
Commemorating World TB Day 2020: “IT’S TIME” — It’s time to End the Global TB Epidemic
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis. Practice-based Recommendations
Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges
Towards tuberculosis elimination: an action framework for low-incidence countries
Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines
Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis
Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes
Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis